Cutaneous fungal infections: innovative treatment schedules with systemic agents.
Brody
N
N
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000935:Antifungal Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001682:Biological Availability; D003881:Dermatomycoses / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D014009:Onychomycosis / Q000188:drug therapy
D000935:Antifungal Agents